Cancer incidence and mortality in Europe, 2004
- PMID: 15718248
- DOI: 10.1093/annonc/mdi098
Cancer incidence and mortality in Europe, 2004
Abstract
Background: There are no recent estimates of the incidence and mortality from cancer at a European level. Those data that are available generally refer to the mid-1990s and are of limited use for cancer control planning. We present estimates of the cancer burden in Europe in 2004, including data for the (25 Member States) European Union.
Methods: The most recent sources of incidence and mortality data available in the Descriptive Epidemiology Group at IARC were applied to population projections to derive the best estimates of the burden of cancer, in terms of incidence and mortality, for Europe in 2004.
Results: In 2004 in Europe, there were an estimated 2,886,800 incident cases of cancer diagnosed and 1,711,000 cancer deaths. The most common incident form of cancer was lung cancer (13.3% of all incident cases), followed by colorectal cancer (13.2%) and breast cancer (13%). Lung cancer was also the most common cause of cancer death (341,800 deaths), followed by colorectal (203,700), stomach (137,900) and breast (129,900).
Conclusions: With an estimated 2.9 million new cases (54% occurring in men, 46% in women) and 1.7 million deaths (56% in men, 44% in women) each year, cancer remains an important public health problem in Europe, and the ageing of the European population will cause these numbers to continue to increase even if age-specific rates remain constant. To make great progress quickly against cancer in Europe, the need is evident to make a concerted attack on the big killers: lung, colorectal, breast and stomach cancer. Stomach cancer rates are falling everywhere in Europe and public health measures are available to reduce the incidence and mortality of lung cancer, colorectal cancer and breast cancer.
Similar articles
-
Estimates of the cancer incidence and mortality in Europe in 2006.Ann Oncol. 2007 Mar;18(3):581-92. doi: 10.1093/annonc/mdl498. Epub 2007 Feb 7. Ann Oncol. 2007. PMID: 17287242 Clinical Trial.
-
Estimates of cancer incidence and mortality in Europe in 1995.Eur J Cancer. 2002 Jan;38(1):99-166. doi: 10.1016/s0959-8049(01)00350-1. Eur J Cancer. 2002. PMID: 11750846
-
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26. Eur J Cancer. 2013. PMID: 23485231
-
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. Eur J Cancer. 2018. PMID: 30100160 Review.
-
Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996.Lung Cancer. 1997 May;17(1):1-60. doi: 10.1016/s0169-5002(97)00648-x. Lung Cancer. 1997. PMID: 9194026 Review.
Cited by 273 articles
-
Incidence and mortality of cancer in the Volta Region of Ghana.Exp Biol Med (Maywood). 2020 Jun;245(12):1058-1065. doi: 10.1177/1535370220931514. Epub 2020 Jun 4. Exp Biol Med (Maywood). 2020. PMID: 32498552
-
A genetic risk assessment for prostate cancer influences patients' risk perception and use of repeat PSA testing: a cross-sectional study in Danish general practice.BJGP Open. 2020 Jun 23;4(2):bjgpopen20X101039. doi: 10.3399/bjgpopen20X101039. Print 2020. BJGP Open. 2020. PMID: 32457098 Free PMC article.
-
LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.Biosci Rep. 2020 Apr 30;40(4):BSR20193172. doi: 10.1042/BSR20193172. Biosci Rep. 2020. PMID: 32149330 Free PMC article.
-
The association between XRCC1 polymorphism and laryngeal cancer susceptibility in different ethnic groups in Xinjiang, China.Int J Clin Exp Pathol. 2018 Sep 1;11(9):4595-4604. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31949858 Free PMC article.
-
Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation.PLoS One. 2019 Oct 11;14(10):e0222885. doi: 10.1371/journal.pone.0222885. eCollection 2019. PLoS One. 2019. PMID: 31603916 Free PMC article.
MeSH terms
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical